Clinical Pharmacy Practice Overview
21 Questions
1 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the first step in the drug prescribing process as outlined?

  • Clinical Examination & Diagnosis by Lab investigations (correct)
  • Monitoring Parameters
  • Patient Education & improving patient adherence
  • Dose Calculation & Administration
  • Which of the following should be considered for dose calculation and administration?

  • Body Weight (BW) or Body Surface Area (BSA) (correct)
  • Patient's recent medical history
  • Physician's previous experience
  • Patient's personal preferences
  • What is included in the monitoring parameters according to the outlined process?

  • Adverse Drug Reactions (ADR) and Drug Interactions (correct)
  • Clinical guidelines for prescribing
  • Patient's education on medication
  • Patient's lifestyle choices
  • When should adjustments be made according to kidney or liver function?

    <p>According to the patient's renal or hepatic status</p> Signup and view all the answers

    What is an important aspect of patient education as per the drug prescribing process?

    <p>Improving patient adherence</p> Signup and view all the answers

    What is the target A1c level recommended by the American Diabetes Association?

    <p>&lt; 7.0%</p> Signup and view all the answers

    What is the recommended before meal glucose level according to American Diabetes Association guidelines?

    <p>80-130 mg/dl</p> Signup and view all the answers

    What should be done if dose adjustments are needed according to kidney or liver function?

    <p>Adjustments are necessary according to kidney or liver function</p> Signup and view all the answers

    Who typically makes the choice of drug and drug therapy?

    <p>The physician</p> Signup and view all the answers

    What is the maximum recommended after meal glucose level?

    <p>&lt; 180 mg/dl</p> Signup and view all the answers

    What follows the prescribing stage in the patient care plan?

    <p>Monitoring parameters</p> Signup and view all the answers

    What is an important aspect of patient education during diabetes management?

    <p>Discuss supportive measures according to guidelines</p> Signup and view all the answers

    What should be monitored for after prescribing a medication?

    <p>Adverse drug reactions and interactions</p> Signup and view all the answers

    Which of the following is NOT a patient factor when selecting a drug?

    <p>Bioavailability</p> Signup and view all the answers

    When considering drug selection and dosage regimen design, which patient factor is specifically relevant for diabetic patients?

    <p>Weight</p> Signup and view all the answers

    Which drug should be avoided in the case of severe liver disease?

    <p>High Dose MTX</p> Signup and view all the answers

    What is a characteristic of drugs that are described as weight-neutral or promote weight loss for diabetes?

    <p>No impact on weight</p> Signup and view all the answers

    Which of the following is a drug factor affecting drug selection?

    <p>Bioavailability</p> Signup and view all the answers

    What patient factor should be particularly considered for dosing adjustments in renal disease?

    <p>Pathophysiology</p> Signup and view all the answers

    Which of the following drugs is commonly used as a first-line treatment for type II diabetes in non-obese patients?

    <p>Sulfonylureas</p> Signup and view all the answers

    Which factor is NOT associated with drug interactions?

    <p>Bioavailability</p> Signup and view all the answers

    Study Notes

    Clinical Pharmacy Practice

    • Clinical pharmacy practice involves the selection and administration of medications, with consideration given to patient factors, drug factors, and disease management.
    • A physician usually chooses the drug and therapy, though pharmacists' input is often sought for drug selections and dosing regimens.
    • Drugs with similar therapeutic use may have disparate pharmacokinetic properties.

    Intended Learning Outcomes

    • Students should learn to assess cases, select drug therapies, and grasp disease management concepts.

    Drug Prescribing Flowchart

    • A flowchart outlining the process of drug selection and administration, encompassing patient history, clinical guidelines, dose calculation considerations, monitoring, patient education, and overall care plan adjustments.
    • Factors like body weight (BW), body surface area (BSA), kidney function, and liver function are crucial for individualizing drug regimens.
    • Adverse Drug Reactions (ADRs) and drug interactions are taken into account in the care plan.

    Diabetes Management Summary

    • Glycemic recommendations for nonpregnant adults with diabetes focus on A1C levels, preprandial capillary plasma glucose, and peak postprandial capillary plasma glucose.
    • 7.0% A1C, 80-130mg/dL preprandial, and <180mg/dL peak postprandial.
    • Individualization is key, taking into account duration of diabetes, age/life expectancy, comorbidities, cardiovascular disease, microvascular complications, and hypoglycemia awareness.

    Diagnosis of Diabetes

    • Diabetes is diagnosed based on blood glucose levels.
    • Normal: <5.7% A1C, Prediabetes: 6.5% A1C, and Diabetes: >6.5% A1C.

    Factors Affecting Drug Selection

    • Patient factors influencing drug choice include age, weight, pathophysiology conditions, nutritional status, genetic variability, and gender.
    • Drug factors include bioavailability, pharmacokinetics (absorption, distribution, and elimination), drug interactions, receptor sensitivity, and metabolism rates.

    Patient Factors: Age, Weight, and Pathophysiology

    • Age and weight influence drug dosage adjustments.
    • Specific pathophysiological conditions require modified treatment plans (e.g., liver disease, renal disease, cardiac disease).

    Patient Factors: Other Considerations

    • Nutritional status and genetic variability need to be factored into decisions about drug selection and dosage.
    • Gender plays a role in drug responses, and adjustments should be made appropriately.

    Oral Anticoagulants

    • Oral anticoagulants (e.g., warfarin) and their associated risks (bleeding) should be carefully considered.
    • Conditions like thrombocytopenia and coagulation defects increase bleeding risk, which may discourage anticoagulant use.

    Genetic Variability

    • Genetic variations (e.g., CYP2C9 and VKORC1) can modify drug response and may warrant dosage adjustments for warfarin to prevent adverse effects.
    • The FDA has provided expected therapeutic dosage ranges for warfarin based on genetic variations.

    Patient Factors: Gender

    • Gender-specific dosage guidelines should be considered.

    Drug Interactions

    • Drug-drug interactions can influence effectiveness and increase toxicity of the drugs.
    • Specific cautions exist for combination use of certain drugs (e.g., ferrous sulfate with PPIs or omeprazole and various acid-reducing drugs.)

    Formulation and Routes of Administration

    • Extended-release drug products offer a longer duration of action.
    • Orally disintegrating tablets may be beneficial for patients with swallowing difficulties.
    • Patients experiencing profuse vomiting or diarrhea.

    Dosage Regimen Design

    • Regimen design aims to achieve the therapeutic concentration of the drug at the receptor site and considers average patients and individual variances in response to therapy.

    Determination of Dosage Form

    • Factors in dosage form selection include bioavailability, absorption, duration of action, and patient-specific factors like cost and compliance.
    • The choice depends on administration concerns, desired onset, response duration and cost.

    Renal Dosing

    • Dosing regimens are tailored for patients with renal impairment.
    • Adjustment of doses may be necessary due to altered kidney function.

    Liver Dosing

    • Dosage adjustments may be needed for patients with liver disease to prevent accumulation and toxicity due to impaired metabolism.

    Determination of Dose and Dose Interval

    • Dose selection depends on factors like average pharmacokinetics, toxicity levels, and minimum inhibitory concentrations.
    • The elimination half-life of the drug often guides the dose interval.

    Special Populations

    • Patients in specific age groups (pediatrics, geriatrics), pregnancies, and certain conditions (obesity, renal, or hepatic disease) may necessitate adjustments to the dosage regimen based on their unique needs.

    Disease Management

    • Disease management (as blended learning) implies programs and plans for the care of chronic conditions such as diabetes.
    • These programs may encompass patient education, self-management support, and coordination of care involving physicians, pharmacists, and other healthcare professionals.

    References

    • Various clinical reference materials are cited.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    Description

    This quiz covers the essentials of clinical pharmacy practice, focusing on medication selection and administration tailored to patient specifics. Students will engage with concepts of drug therapy assessment, disease management, and comprehensive care planning, including the use of flowcharts to guide prescribing decisions.

    Use Quizgecko on...
    Browser
    Browser